3NJ-62449-88426
2 vaccinations
6 coded responses
23 check-ins
6 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 300 / GA
- Registered
- 2022-07-06
- Relationship
- Child or adolescent in my care
- Guardian
- UR4-14911-26243
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-06
Registered in v-safe
-
2022-07-06
Dose 1 — Pfizer-BioNTech
- 2022-07-07
- 2022-07-08
-
2022-07-09
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-10
- 2022-07-11
- 2022-07-12
- 2022-07-13
-
2022-07-20
Survey response — day 14, dose 1, under 3MedDRA: Body temperature increased, Cough, Fatigue, Irritability — Feeling: Fair · Be unable to work or attend schoolFree text: Low fever (99.8) started 07/19/22, cough, fatigue, mild irritabilityMedDRA releases: 2024-11 · check-in free text available
-
2022-07-27
Survey response — day 21, dose 1, under 3MedDRA: Cough, Discomfort, Nasal congestion, Pyrexia, Rhinorrhoea, Self-medication — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever, cough, runny nose 7/19/22 through 7/25/22. Fever and nasal congestion resolved 7/25/22, but residual post viral cough remains. Treated with albuterol nebulizer q4hours on 7/21, 7/22, 7/23. Also treated with ibuprofen for discomfort.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-27
Report sent to call center — day 21, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-28
- 2022-08-05
-
2022-09-20
Dose 2 — Pfizer-BioNTech
-
2022-09-20
Survey response — day 0, dose 2, under 3MedDRA: Pre-existing disease — Feeling: GoodFree text: (b)(6) is a Type 1 Diabetic, if that is important to your dataMedDRA releases: 2024-11 · check-in free text available
-
2022-09-21
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Blood glucose increased — Feeling: Good · Irritability/cryingFree text: (b)(6) has high blood sugar last night - he was 423mg/dL at 11pm which was abnormal for himMedDRA releases: 2024-11 · check-in free text available
- 2022-09-22
- 2022-09-23
-
2022-09-26
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: (b)(6) has a runny nose todayMedDRA releases: 2024-11 · check-in free text available
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
-
2022-12-20
Survey response — 3 months, dose 2, under 3MedDRA: Asthma, Dyspnoea, Hospitalisation, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: (b)(6) was diagnosed with asthma on 11/15/22 after two hospitalizations 11/08-11/11 and 11/13-15 for RSV and increased work of breathing.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-20
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-12-21
- 2022-12-21
- 2023-03-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-06 | Pfizer-BioNTech | No |
| 2 | 2022-09-20 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Low fever (99.8) started 07/19/22, cough, fatigue, mild irritability
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Fever, cough, runny nose 7/19/22 through 7/25/22. Fever and nasal congestion resolved 7/25/22, but residual post viral cough remains. Treated with albuterol nebulizer q4hours on 7/21, 7/22, 7/23. Also treated with ibuprofen for discomfort.
Release 12 (Under 3) — day 0, dose 2, under 3
Systemic reaction (other): (b)(6) is a Type 1 Diabetic, if that is important to your data
redacted (b)(6)
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): (b)(6) has high blood sugar last night - he was 423mg/dL at 11pm which was abnormal for him
redacted (b)(6)
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: (b)(6) was diagnosed with asthma on 11/15/22 after two hospitalizations 11/08-11/11 and 11/13-15 for RSV and increased work of breathing.
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Discomfort | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hospitalisation | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SRO | Blood glucose increased | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release